Akebia Therapeutics (AKBA) Posts Q2 Loss of 40c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq futures slip on chip weakness; S&P 500 holds gains
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
| AKEBIA THERAPEUTICS (NASDAQ: AKBA) | Delayed: 0.69 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.69 | 52 Week High | $13.20 | |||
| Open | $0.69 | 52 Week Low | $7.00 | |||
| Day High | $0.69 | P/E | N/A | |||
| Day Low | $0.69 | EPS | $0.00 | |||
| Volume | 254,931 | |||||
